Free Trial

Todd P. Kelsey Sells 1,500 Shares of Plexus Corp. (NASDAQ:PLXS) Stock

Plexus logo with Computer and Technology background

Plexus Corp. (NASDAQ:PLXS - Get Free Report) CEO Todd P. Kelsey sold 1,500 shares of the business's stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $136.96, for a total value of $205,440.00. Following the sale, the chief executive officer now owns 86,932 shares in the company, valued at approximately $11,906,206.72. The trade was a 1.70 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Plexus Stock Down 0.6 %

Shares of NASDAQ:PLXS traded down $0.82 during trading on Friday, reaching $141.13. 194,588 shares of the company traded hands, compared to its average volume of 186,843. The firm has a fifty day simple moving average of $158.56 and a 200 day simple moving average of $144.08. The company has a quick ratio of 0.70, a current ratio of 1.53 and a debt-to-equity ratio of 0.07. Plexus Corp. has a 1-year low of $90.18 and a 1-year high of $172.89. The firm has a market cap of $3.82 billion, a P/E ratio of 32.74 and a beta of 0.89.

Plexus (NASDAQ:PLXS - Get Free Report) last released its quarterly earnings data on Wednesday, January 22nd. The technology company reported $1.49 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.59 by ($0.10). Plexus had a net margin of 3.03% and a return on equity of 10.36%. Analysts anticipate that Plexus Corp. will post 5.94 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Benchmark reissued a "buy" rating and issued a $165.00 target price on shares of Plexus in a research report on Wednesday, January 22nd. Stifel Nicolaus started coverage on shares of Plexus in a research report on Tuesday, February 4th. They set a "hold" rating and a $152.00 price objective on the stock. StockNews.com upgraded Plexus from a "hold" rating to a "buy" rating in a report on Monday, November 18th. Needham & Company LLC lifted their price target on Plexus from $162.00 to $172.00 and gave the company a "buy" rating in a report on Friday, January 24th. Finally, KeyCorp assumed coverage on Plexus in a research note on Tuesday, October 22nd. They issued a "sector weight" rating for the company. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $163.00.

View Our Latest Stock Report on PLXS

Hedge Funds Weigh In On Plexus

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PLXS. HighTower Advisors LLC raised its holdings in shares of Plexus by 10.3% during the 4th quarter. HighTower Advisors LLC now owns 2,975 shares of the technology company's stock valued at $466,000 after purchasing an additional 278 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Plexus by 21.9% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,140 shares of the technology company's stock worth $1,117,000 after buying an additional 1,284 shares during the last quarter. Sowell Financial Services LLC bought a new position in Plexus during the fourth quarter valued at about $2,140,000. AlphaQuest LLC acquired a new stake in shares of Plexus in the fourth quarter worth about $1,516,000. Finally, Amundi boosted its stake in shares of Plexus by 192.1% during the 4th quarter. Amundi now owns 14,000 shares of the technology company's stock worth $2,289,000 after acquiring an additional 9,207 shares in the last quarter. Institutional investors own 94.45% of the company's stock.

About Plexus

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

See Also

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Should You Invest $1,000 in Plexus Right Now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines